Kuala Lumpur–United Crest Healthcare (“United”) announced announced on December 18, 2017 that United has signed an agreement with Pathway Genomics Corporation (“Pathway”) to provide DNA tests in the Asia-Pacific region. Pathway, a CLIA certified and CAP accredited clinical laboratory based in San Diego, California, specializes in genetic testing and analysis. In addition to the ASEAN countries, United will also offer these services in China, Russia, and Taiwan.
As part of United’s strategic development imedic™ Cloud Hospital eco-system, United is partnering with Pathway to offer personalized DNA tests as part of the imedic™ healthcare services to their patients in working with hospitals, doctors and patients in Asia.
The DNA tests are easily collected with buccal swab at home or at the nearest participating clinics to be sent to Pathway’s clinical laboratory for processing. Pathway produces results of the DNA test with a patient report in 2-3 weeks on the mobile APP of imedic™ or online at Pathway.com.
In recent years, genetic testing has been widely promoted by doctors as part of a wellness program or diagnosis in determining diseases more accurately. Pathway’s wide portfolio of DNA testing services cover a variety of conditions including somatic and hereditary cancer, cardiac health, carrier screening, diet and weight loss, as well as drug response for specific medications including those used in pain management and mental health. Families with history of cancer, cardiovascular diseases, diabetes, obesity and hereditary diseases are generally encouraged to have the relevant DNA tests done for preventive purposes.
Michael Nova, the chief innovation officer and co-founder of Pathway, stated:
“We are excited to bring the leading DNA test services of Pathway to Asia. These advanced and affordable DNA tests will help millions of people to precisely identify their predisposed conditions and take the necessary measures to prevention and/or personalized treatment.”
Kah Yee Eg, founder and CEO of United Crest Healthcare, added:
“The test results will be integrated into the digital medical record for analysis powered by the Artificial Intelligence capability of imedic™ platform.”
About United Crest Healthcare:
United Crest Healthcare is the leading mobile health platform developer and operator with its imedic™ Cloud Hospital used by thousands of doctors and patients in the US, Russia, China and other Asian countries. imedic™ is powered by advanced Artificial Intelligence and knowledge based technology for comprehensive analysis of users’ health data to produce timely and accurate health information.
About Pathway Genomics:
Founded in 2008, Pathway Genomics is a DNA testing company, which focuses on health and wellness. Based in San Diego, our CLIA certified and CAP accredited clinical laboratory provides physicians and their patients in 40+ countries with accurate and actionable personalized healthcare information. Pathway’s analysis, in combination with IBM Watson, merges artificial intelligence and deep learning to provide users with the most precise and personalized health guides available. For more about Pathway Genomics, visit www.pathway.com